权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

COBRE:Eukaryotic Pathogens Innovation Center (EPIC)

COBRE：真核病原体创新中心（EPIC）

基本信息

批准号：
9900800
负责人：
LESLY A TEMESVARI
金额：
$ 200.61万
依托单位：
CLEMSON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-04-15 至 2022-07-14
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9900800
关键词：
Acetates African African Trypanosomiasis Amebic colitis Aneuploidy Area Assistantship Biogenesis Biology Bioterrorism Cardiovascular Diseases Cell Separation Centers of Research Excellence Chagas Disease Communicable Diseases Complement Complex Core Facility Cryptococcus neoformans Detection Development Diagnosis Disease Drug resistance Dysentery Entamoeba histolytica Environment Environmental Risk Factor Equilibrium Equipment Faculty Faculty Recruitment Fatty Acids Fermentation Fluconazole Fostering Funding Future Genomics Glucose Glycosome Goals Government Grant Host Defense Human Image Incidence Infection Infrastructure Interdisciplinary Study Knowledge Leadership Malaria Mass Spectrum Analysis Medical Meningitis Mentors Metabolism Microbial Genetics Modeling Oral health Organelles Parasitic Diseases Parasitic infection Participant Pathogenesis Peer Review Grants Phenotype Pilot Projects Probability Program Research Project Grants Research Research Personnel Resource Allocation Role Scientist South Carolina Talents Targeted Research Training Trypanosoma Trypanosoma brucei brucei United States National Institutes of Health Universities Variant Virulence base dietary supplements drug discovery genetic evolution hexokinase human disease innovation insight member multidisciplinary neglected tropical diseases oxidant stress pathogen programs public health relevance recruit senior faculty skills success tissue regeneration transmission process vaccine development vector

项目摘要

DESCRIPTION (provided by applicant): Eukaryotic pathogens are the causative agents of some of the most devastating and intractable diseases of humans, including malaria, amebic dysentery, sleeping sickness, Chagas disease, and meningitis. The global impact of these diseases is immense. It is noteworthy that many of these pathogens are the causative agents of neglected tropical diseases (NTDs) and/or are also classified as bioterrorism agents. Importantly, infections caused by eukaryotic pathogens are increasing in the US due to globalization. The primary goal of this COBRE proposal is to increase the number of NIH-funded scientists in the state of South Carolina by establishing a world-class research center, the Eukaryotic Pathogens Innovation Center (EPIC), at Clemson University (CU). The scientific focus of EPIC will be a multidisciplinary study of important global eukaryotic pathogens. Five projects from target junior investigators will be supported. Their projects are 1) The role of acetate fermentation in Entamoeba histolytica virulence; 2) Glycosome biogenesis in African trypanosomes; 3) Glucose Sensing and Hexokinases in the African Trypanosome; 4) Fatty acid synthesis in Trypanosoma brucei, and 5) Exploring the mechanisms of fluconazole-induced aneuploidy in Cryptococcus neoformans. These investigators will be matched with mentors who are established NIH-funded researchers. The projects will be supported by a well-organized Administrative Core and two state-of-the-art Scientific Cores in Genomics, Imaging and Cell Sorting, and Mass Spectroscopy. The Scientific Cores will also benefit at least two other COBRE-funded centers in the state of South Carolina and other faculty at CU. The center also has a substantial infrastructure base and significant institutional support. For example, CU will recruit three additional investigators to expand activities of this center over the course of the project period. Pledges of graduate assistantships, equipment, and space further exemplify the institutional commitment. This COBRE-funded center will significantly expand research in South Carolina and will facilitate recruitment, training, and retention of a critical mass of investigatos with cross-disciplinary skills in this important research area.

描述（由申请人提供）：真核病原体是一些最具破坏性和最难治的人类疾病的病原体，包括疟疾、阿米巴痢疾、昏睡病、恰加斯病和脑膜炎。这些疾病的全球影响是巨大的。值得注意的是，其中许多病原体是被忽视的热带病的病原体和/或也被列为生物恐怖主义病原体。重要的是，由于全球化，真核病原体引起的感染在美国正在增加。COBRE提案的主要目标是通过在克莱姆森大学（CU）建立一个世界级的研究中心--真核病原体创新中心（EPIC），来增加南卡罗来纳州NIH资助的科学家的数量。EPIC的科学重点将是对重要的全球真核病原体进行多学科研究。将支助目标初级调查员的五个项目。他们的项目包括：1）醋酸发酵在溶组织内阿米巴毒力中的作用; 2）非洲锥虫中的糖体生物发生; 3）非洲锥虫中的葡萄糖传感和己糖激酶; 4）布氏锥虫中的脂肪酸合成; 5）探索新型隐球菌中氟康唑诱导的非整倍性机制。这些研究人员将与NIH资助的知名研究人员导师相匹配。这些项目将得到一个组织良好的行政核心和两个最先进的科学核心的支持，在基因组学，成像和细胞分选，质谱。科学核心还将使南卡罗来纳州至少另外两个COBRE-funded中心和CU的其他教师受益。该中心还拥有坚实的基础设施和重要的机构支持。例如，CU将招聘三名额外的调查员，以扩大该中心在项目期间的活动。研究生助学金，设备和空间的承诺进一步巩固了机构的承诺。这个由COBR资助的中心将显着扩大南卡罗来纳州的研究，并将促进招募、培训和保留大量在这一重要研究领域具有跨学科技能的调查人员。

项目成果

期刊论文数量（68）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

A targeted delivery strategy for the development of potent trypanocides.

开发强效锥虫杀剂的靶向递送策略。

DOI：
10.1039/c7cc03378h
发表时间：
2017
期刊：
Chemical communications (Cambridge, England)
影响因子：
0
作者：
Gordhan,HeerenM;Milanes,JillianE;Qiu,Yijian;Golden,JenniferE;Christensen,KennethA;Morris,JamesC;Whitehead,DanielC
通讯作者：
Whitehead,DanielC

The Tiger Rattlesnake genome reveals a complex genotype underlying a simple venom phenotype

虎响尾蛇基因组揭示了简单毒液表型背后的复杂基因型

DOI：
10.1073/pnas.2014634118
发表时间：
2021
期刊：
Proceedings of the National Academy of Sciences
影响因子：
0
作者：
Margres, Mark J.;Rautsaw, Rhett M.;Strickland, Jason L.;Mason, Andrew J.;Schramer, Tristan D.;Hofmann, Erich P.;Stiers, Erin;Ellsworth, Schyler A.;Nystrom, Gunnar S.;Hogan, Michael P.
通讯作者：
Hogan, Michael P.

The blackgrass genome reveals patterns of non-parallel evolution of polygenic herbicide resistance.

DOI：
10.1111/nph.18655
发表时间：
2023-03
期刊：
NEW PHYTOLOGIST
影响因子：
9.4
作者：
Cai, Lichun;Comont, David;MacGregor, Dana;Lowe, Claudia;Beffa, Roland;Neve, Paul;Saski, Christopher
通讯作者：
Saski, Christopher

Continuous sheath-free separation of drug-treated human fungal pathogen Cryptococcus neoformans by morphology in biocompatible polymer solutions.